The biotech world just got a big reminder that artificial intelligence is no longer just a supporting tool—it’s becoming the engine that drives discovery itself. Chai Discovery, a fast-growing biotechnology company backed by OpenAI, has successfully raised $130 million in Series B funding, pushing its valuation to $1.3 billion. The deal places Chai Discovery firmly …